EP
ATRC icon

Essential Partners’s AtriCure ATRC Stock Holding History

Essential Partners’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.76K Sell
63
-305
-83% -$8.58K ﹤0.01% 2030
2026
Q1 		$10.5K Buy
368
+330
+868% +$11.3K ﹤0.01% 1233
2025
Q4 		$1.5K Sell
38
-21
-36% -$770 ﹤0.01% 1898
2025
Q3 		$2.08K Buy
59
+39
+195% +$1.34K ﹤0.01% 1777
2025
Q2 		$655 Buy
+20
New +$650 ﹤0.01% 1625

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Essential Partners's ATRC Position: Q2 2026 in Review

Essential Partners reduced its AtriCure (ATRC) stake by 83% in Q2 2026, selling an estimated $8.58K and leaving 63 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Essential Partners first reported a position in ATRC in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.5K in Q1 2026. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Essential Partners held 63 shares of AtriCure worth $1.76K as of Q2 2026.
  • Essential Partners sold 305 AtriCure shares in Q2 2026, an estimated $8.58K.
  • AtriCure made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2030 holding.
  • Essential Partners first reported a position in AtriCure in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's AtriCure position peaked at $10.5K in Q1 2026.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.